Schedule 13G ownership disclosure
Evolent Health Inc
Class A Common Stock, par value $0.01 per share · CUSIP: 30050B101
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Cadian Capital Management, LP
Shares: 10,794,606 · Class: 9.3%
- Cadian Capital Management GP, LLC
Shares: 10,794,606 · Class: 9.3%
- ERIC BANNASCH
Shares: 10,794,606 · Class: 9.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001011438-25-000315
- Form type
- SCHEDULE 13G
- Filer
- CADIAN CAPITAL MANAGEMENT, LP
- CIK
- CIK 1423686
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership